Want to see FR:EMEIS full AI Analyst Report?
EMEIS Stock Chart & Stats
€14.02
-€0.28(-4.80%)
At close: 4:00 PM EST
€14.02
-€0.28(-4.80%)
Day’s Range― - ―
52-Week Range€10.43 - €16.19
Previous CloseN/A
Volume457.99K
Average Volume (3M)485.78K
Market Cap
€2.25B
Enterprise Value€10.47B
Total Cash (Recent Filing)€337.09M
Total Debt (Recent Filing)€8.60B
Price to Earnings (P/E)―
Beta1.12
Next Earnings
Sep 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.85
Shares Outstanding161,440,050
10 Day Avg. Volume432,757
30 Day Avg. Volume485,783
Financial Highlights & Ratios
PEG Ratio0.26
Price to Book (P/B)1.64
Price to Sales (P/S)0.39
P/FCF Ratio4.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€16.00Price Target Upside14.12% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)-0.79
Revenue Forecast (FY)€6.07B
Bulls Say, Bears Say
Bulls Say
Free Cash Flow TurnaroundThe company converted a prior cash shortfall into consistently positive operating and free cash flow in 2025, providing durable internal funding for operations, capex and debt service. Sustained cash generation reduces refinancing dependence and underpins deleveraging and investment flexibility over months to years.
Revenue And Occupancy RecoveryImproving occupancy and steady like‑for‑like revenue growth signal recovery of core demand and pricing power in long‑term care. Higher utilization drives durable revenue visibility and operational leverage, supporting sustainable margin expansion if maintained across regions and new facility ramps.
Deleveraging Via Disposals And RefinancingA material disposal program plus full refinancing materially improved liquidity and reduced gross leverage, creating structural headroom to meet covenants and invest in operations. This balance‑sheet repair lowers default and refinancing risk and supports strategic optionality over the medium term.
Bears Say
Very High LeveragePersistently elevated leverage constrains financial flexibility and raises interest and covenant sensitivity, limiting capacity for acquisitions or cyclical stress absorption. Even with recent improvements, high gross debt relative to equity materially increases refinancing and solvency risk over the coming quarters.
Ongoing Net Losses And One-off ChargesReported net losses and large exceptional charges undermine persistent profitability metrics and impede return thresholds needed for dividends or buybacks. If nonrecurring items normalize slower than expected, accounting losses could persist despite cash generation, limiting shareholder returns and rating improvement.
Interest-rate And Hedging ExposureSubstantial unhedged variable‑rate debt leaves interest expense and cash flow exposed to short‑term rate moves. Over a 2–6 month horizon, rising rates could inflate financing costs and slow deleveraging, eroding operating cash flow margins and putting pressure on covenant headroom.
Orpea SA News
EMEIS FAQ
What was Orpea SA’s price range in the past 12 months?
Orpea SA lowest stock price was €10.43 and its highest was €16.19 in the past 12 months.
What is Orpea SA’s market cap?
Orpea SA’s market cap is €2.25B.
When is Orpea SA’s upcoming earnings report date?
Orpea SA’s upcoming earnings report date is Sep 23, 2026 which is in 71 days.
How were Orpea SA’s earnings last quarter?
Orpea SA released its earnings results on Apr 08, 2026. The company reported -€0.998 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Orpea SA overvalued?
According to Wall Street analysts Orpea SA’s price is currently Undervalued.
Does Orpea SA pay dividends?
Orpea SA pays a Notavailable dividend of €57.478 which represents an annual dividend yield of N/A. See more information on Orpea SA dividends here
What is Orpea SA’s EPS estimate?
Orpea SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Orpea SA have?
Orpea SA has 161,440,050 shares outstanding.
What happened to Orpea SA’s price movement after its last earnings report?
Orpea SA reported an EPS of -€0.998 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 6.96%.
Which hedge fund is a major shareholder of Orpea SA?
Currently, no hedge funds are holding shares in FR:EMEIS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Orpea SA
Emeis Société anonyme operates as a prominent provider of diverse healthcare services, encompassing the management of nursing homes, assisted-living facilities, specialized post-acute and rehabilitation hospitals, and psychiatric treatment centers. Within its elderly care residences, the company delivers tailored support alongside comprehensive logistical and residential amenities, including comfortable accommodation, meal services, laundry, and room maintenance. These facilities also enrich residents' lives with a variety of daily events, recreational activities, and therapeutic workshops. Emeis's post-acute and rehabilitation hospitals are equipped to treat a wide array of medical conditions, such as geriatric issues, musculoskeletal and neurological disorders, cardiovascular and hematological ailments, oncology recovery, and care for individuals in persistent vegetative or minimally conscious states. The psychiatric hospitals address an extensive spectrum of mental health concerns, ranging from mood, anxiety, and obsessive-compulsive disorders to addictions, eating disorders, sleep disturbances, personality disorders, age-related psychiatric conditions, psychosis, and stress-induced conditions like burnout, chronic fatigue syndrome, fibromyalgia, psychosomatic issues, and post-traumatic stress disorder. Furthermore, they offer specialized psychiatric care for geriatrics, children, young adults, and parent-child dynamics, serving both public and private patients. Complementing its institutional offerings, Emeis also provides comprehensive home care solutions. These include practical domestic assistance such as cleaning, meal preparation, ironing, gardening, and running errands; daily living support encompassing day or night supervision and aid with hygiene and meals; and mobility assistance. Founded in 1989 and headquartered in Puteaux, France, the company maintains an expansive international presence, with operations spanning numerous countries across Europe, Latin America, and Asia, including France, Belgium, Spain, Italy, Ireland, Switzerland, Austria, Germany, the Czech Republic, Poland, the Netherlands, Luxembourg, Portugal, Brazil, Russia, Slovenia, Uruguay, Colombia, Mexico, Chile, Latvia, Croatia, and China.
EMEIS Stock 12 Month Forecast
Average Price Target
€16.00
▲(14.12% Upside)
Technical Analysis
Eurofins Scientific
―
Clariane
―
LNA Sante SA
―
Equasens
―
Ramsay Generale de Sante
―
Options Prices
Currently, No data available
---
